Aims:
The high prevalence of obesity, needs urgently the development of new, highly active antiobesic drugs. Here we report on the antiobesic activity of a new anorectic compound HMR1426, (chloro-2-phenyl-8, 8a-dihydro-indenol [1,2-d] thiazol -3a-ol) in Zucker fatty rats, fed a fat rich diet. Methods: Two groups, N=12, were kept on standardised conditions. The duration of the study was 5 weeks, with an initial assimilation period of 2 weeks, when all rats were fed a standard diet (1 g feed=12.1 kJ). From week three on, HMR1426 (50 mg/kg po). was administered daily. All animals now received the fat rich diet (FRD), (1 g feed=22 kJ). Feed consumption and BW was measured daily. Results: During the assimilation phase, energy consumption (EC) was nearly identical in both groups. During the drug treatment period, EC in rats receiving HMR1426, dropped immediately by~80%. Energy consumption stayed on this low level until the end of the study. Consequently HMR1426 treated rats, lost 33% of their BW. At the end of the study the following serum parameters were significantly decreased in the HMR1426 treated rats, compared with the solvent treated Zucker fatty rats: glucose (33%), insulin (59%) cholesterol (34%), triglycerides (80%) and leptin (33%). There was a significant correlation between BW and serum levels of leptin.
Conclusions:
The anorectic effect of HMR1426 did not fade out during the study. The loss in BW of the HMR1426 treated rats was accompanied by an improvement of obesity and diabetes related parameters. The marked antiobesic effects of HMR1426 in Zucker fatty rats fed a fat rich diet is presumably caused by the loss in fat tissue. This view is strongly supported by the close correlation between BW and serum leptin in this study.
Changes in self-reported food intake before, during and after a weight maintenance intervention in obese men P. Borg, K. Kukkonen-Harjula, M. Fogelholm UKK Institute, Tampere, Finland Aims: Aim was to assess changes in food consumption before, during and two years after dietary counselling. Methods: 90 obese men participated in a 2-month (mo) weight reduction (WR) phase using VLED. WR was followed by a 6-mo weight maintenance (WM) program. Both of these phases included dietary counselling. WM was followed by 2-year follow-up. Dietary intake was assessed by 4-day food records before the study (-1 mo), before WR (0 mo), after WR (2 mo), after WM (8 mo), and at yearly follow-up assessments (20 and 31 mo). The data is presented from 36 subjects with complete dietary assessment during the study. Results: Increased consumption of low-fat cheese, vegetables and high-fibre bread, and decreased consumption of sugar, sausage, high-fat cheese and margarine, other fat products and candies were observed during dietary counselling. Except decreased intake of sausage and high-fat cheese, these changes returned to prestudy consumption level during follow-up. Conclusions: Maintenance of dietary changes is apparently difficult. New ways to ease self-monitoring and increase palatability of a less energy-dense diet are needed. Aims: An evaluation of multidisciplinary intervention concentrating on healthy eating practices, regular moderate exercise and behaviour modification, using the SelfDetermination Theory.
T4:P4-
Methods: A RCT, incorporating a delayed start control group. 62 pre-menopausal clinically obese women participated in a 12 months community-based weight management programme. The trial incorporated a 3 month intensive intervention phase (4-6 times a week) followed by 9 months maintenance phase. Mixed-methodological assessments were undertaken at 3, 6 and 12 months including psychological questionnaires, interviews, cardiorespiratory fitness, body composition, metabolic and dietary measures. Results: Participants' experienced improved self-esteem, reported less stress, felt more in control of their lives. Participants' body composition, fitness and lipoprotein-lipids improved at 3 and 6 months. Physical and psychological benefits were sustained up to 12 months. Conclusions: Behavioural weight management (underpinned by self-determination theory) was successful in encouraging a healthier lifestyle, improved psychological functioning and moderate long-term weight loss.
Body composition changes during 4 years of treatment with orlistat vs. placebo (The XENDOS study)
Brandberg J, Lönn L, Peltonen M, Torgerson JS, Sjöström L. Sahlgrenska University Hospital, Göteborg Sweden Aim: To study changes in body composition during 4 years of treatment with orlistat (ORL) vs. placebo (PL). Methods: Body composition changes after ORL (81 subjects) or PL (43 subjects) were studied using CT and DXA. All subjects had a BMI ≥ 30 kg/m 2 . Tissue areas of 25 compartments, mainly adipose tissue (AT) areas, were analyzed at 3 levels: neck (C4), abdomen (L4) and mid-thigh (Th). Results: After one year intermuscular AT (IMAT) and subcutaneous AT (SAT) decreased more at the C4 level in the ORL-group. The difference remained for SAT after 4 years. At the L4 level SAT and visceral AT (VAT) decreased more in the ORLgroup. For VAT the difference remained after 4 years. At the Th level total AT, SAT and muscle tissue area decreased more after 1 year in the ORL group. DXA body fat and lean body mass were lower in the ORL-group after 1 year. All changes in results are statistically significant. Conclusion: After 1 year there was a reduction in several tissue compartments, especially adipose tissue areas. After 4 years visceral adipose tissue and neck subcutaneous tissue were still lower in the ORL group. Reductions in VAT have previously been related with reduced cardiovascular risk factors.
Time course for weight loss-induced improvements in components of the metabolic syndrome in obese adults
Boulé NG, Doucet E, Imbeault P, Tremblay A Laval University, Québec, Canada Aims: To compare the short term and medium term effects of weight loss on components of the metabolic syndrome. Methods: 21 males and 25 females (non-diabetic, age=43+5 years, BMI=36+5 kg/m 2 ) were recruited for a 15-week weight loss study consisting of a 700 kcal/day energy restriction combined with fenfluramine (60mg/day) or placebo. Results: Body mass, waist circumference and percent body fat were reduced gradually by approximately 10% at the end of the 15-week intervention (p<0.01). This weight loss was associated with reductions in LDL cholesterol (-9%, p<0 .01), triglycerides (-24%, p<0.01), blood pressure (-9%/-5%, p<0.01) and fasting insulin (-11%, p<0.05) . The majority of these improvements were also present at week 2 of the study even if body mass was only reduced by 1%: LDL cholesterol (-14%, p<0.01), blood pressure (-8%/-6%, p<0.01) and fasting insulin (-19%, p=0.06 ). There was no significant effect of sex or group assignment on these variables. Plasma triglycerides decreased proportionally to weight loss during the program and fasting glucose did not change. Conclusions: Many of the beneficial effects of a weight loss intervention on the metabolic syndrome can be observed as soon as 2 weeks after the beginning of the intervention.
Aims: Weight loss is one of the most efficacy nonpharmacologic measures in the control of hypertensive patients. The purpose of this study was to evaluate the effects of Orlistat in obese hypertensive patients. Methods: We studied 68 obese patients with mild-tomoderate essential untreated hypertension. After 4 weeks of diet, patients were randomly distributed either to continue with their low-calorie and low-sodium diet (23 patients), or to receive 360 mg/day Orlistat for 16 weeks in addition to the diet. Clinical (SBP, DBP, BMI, waist perimeter) and biochemical-metabolic parameters (insulin sensibility, IS, and lipid profile) were evaluated before and after treatment. Results: After 16 weeks of follow-up, there was an average weight loss of 12.2% with Orlistat and 7.5% with diet (P<0.001). The average reduction in waist perimeter was 10.6 vs. 7.2 (P<0.001). SBP and DBP were reduced by 8.3/4.2 mm Hg with Orlistat vs. 2.1/1.4 mm Hg with diet (P=0.001). There was an improvement in IS and lipid profile only in the group treated with Orlistat. Conclusions: In obese hypertensive patients, Orlistat is efficient in reducing overweight, with an associated reduction in BP and improvement in lipid metabolic profile.
Sibutramine vs placebo: anthropometric evaluation of obese women in a double-blind, controlled study. Campanaro P, Dragani B, Pompilii S, Di Bonifacio MT, De Cristofaro P, Centro Regionale Nutrizione, ASL-Teramo, Giulianova, Italy Aims: The aim of the authors has been to verify the quality of weight loss through dynamics anthropometric evaluation. Methods: 10 obese women (BMI≥30), ages 20-50 years, randomized, have followed an hypocaloric standard diet (minus 500kcal approximately regarding the daily requirements) and taken sibutramine 10mg/die for 6 months in a double-blind study, controlled vs a diet plus placebo sample of 10 women with the same characteristics. Body weight, BMI, abdominal circumference, sagittal abdominal diameter, skinfold thickness, muscular (AMA-TMA) and fat (AFA-TFA) mass areas of arm and thigh respectively, have been compared between beginning and end of the study. Results: Not meaningful differences in the two groups for variations of body weigh, BMI, abdominal circumference, AMA and TMA. Much meaningful differences, instead, in the group treated with sibutramine, the variations of sagittal abdominal diameter, all skinfold thickness, AFA and TFA. Conclusions: The treatment with sibutramine has been synergic with the diet to favour the selective loss of body fat, preserving the muscular mass. The use of a standard impersonal diet, has prevented to obtain stable and coherent alimentary behaviours, for which body weight reduction has not statistically meaningful. 
T4:P4-020
Long-term evaluation of protein malnutrition in morbidly obese patients operated with lap-band Casañ R, Solá E, Morillas C, Garzón S, García S, Aims: To evaluate the rate of protein malnutrition in MO patients long-term after LAGB operation. Methods: The level of serum-albumin (Album), plasmaprealbumin (Prealb), transferrin, plasma retinol binding globulin (RBG), C3-complement factor (C3) and lymphocytes were measured before and at less 3 years after LAGB intervention. In addition, creatinine height index (CHI) were measured to assess the muscular protein malnutrition. The statistic method used was test t. 15 patients were included. Results: A tendency todecrease everyone of these parameters was observed. The difference between initial values and after 36 months in levels of serum-albumin, transferrin, and plasma retinol binding globulin was statistically significant (p<0,05). Only 2 patients (13,3%) had serum-albumin values under normal levels, and 1 patient (6,6%) had transferrin values under normal levels. Conclusions: A tendency to visceral protein malnutrition was observed. In spite of the decrease of these values, most of them were placed in normal levels. There were no modifications in muscular protein malnutrition parameters (CHI).
Effect of an energy reduced high protein red meat diet on weight loss and metabolic parameters in obese women Noakes M, Clifton PM, Keogh J, Foster P CSIRO Health Sciences and Nutrition, Adelaide, Australia
The role of high protein diets in weight loss is unclear. Aim: To determine the effects on weight loss, fat & lean body mass, metabolic parameters & markers of bone turnover of reduced energy intake with increased protein from red meat. Methods: 12 week randomised parallel design of two 5600KJ diets: High meat (HM) 34% protein 46% carbohydrate 20% fat or low meat (LM) 17% protein 64% carbohydrate 20% fat. Results (Mean ± SD): 100 women completed the study. Weight loss: -7.6 ± 3.3 (HM) & -6.9 ± 3.5 kg (LM). Fat & lean mass changes were different from baseline but not between diets. Subjects with high TG (>1.5mmol/L) had greater loss of weight on the HM diet 7.9±0.7 versus 5.9±0.4kg (P=0.02). TG fell by 8-22% HDL cholesterol fell 5-8% and LDL cholesterol & glucose fell by 7% & 4% respectively with no differences between diets. Vitamin B12 increased by 9% on HM & fell by 13% on LM (p<0.01). Markers of bone turnover increased by 8 -12% & urine calcium decreased by 1mmol/day, with no differences between diets. Conclusion: A low energy diet high in red meat seems to be an advantage to subjects with features of the metabolic syndrome with no adverse effects on bone metabolism. 
How effective are meal replacements?
Clifton P M, Noakes M, Keogh J Foster P CSIRO Health Sciences and Nutrition, Adelaide, Australia It is unknown how effective meal replacements are in a minimal intervention, controlled trial. Aim: To compare the use of meal replacements with standard written advice on a low fat reduction diet in overweight Australians with a triglyceride > 2 mmol/L. Methods: Every 2 weeks product was supplied to the meal replacement (MR) & shopping vouchers supplied to the control (C) groups. Weight was taken every 2 weeks. Results: 55 subjects completed. At 3 months weight loss was 6Kg in MR & 6.6kg in C group. 19 MR & 20 C subjects continued to 6 months when weight loss was 9.0kg in MR & 9.2 kg in C group. At 12 weeks triglyceride fell in the C group (0.48 mmol/L or 25%) but not in the MR group (4%) & there was a significant interaction with diet. At 24 weeks there was a fall of 18% in MR group and no further change in the C group. At 3 months PAI-1 fell in the C group, & sICAM1 fell in both groups. Pulse wave velocity decreased with weight loss but flow mediated dilatation did not change. Conclusion: Meal replacement is an effective strategy for weight loss which is maintained to 6 months. It is associated with lower triglyceride, circulating adhesion molecules & pulse wave velocity. Participants found MR easy to comply with & found it easier to dine out on the MR plan.
Postprandial insulin and glucose response to three high protein mixed meals: effect of varying source of dietary protein in obese women Bowen J, Noakes M, Foster P, Clifton PM CSIRO, Health Sciences & Nutrition, Adelaide, Australia High protein diets are often used to promote weight loss. It is not clear if type of protein is important. Aim: To investigate if source of dietary protein in a mixed meal affects postprandial glucose and insulin response in obese women. Methods: Randomised, cross-over design of 3 meals: 2.4MJ, 43g protein, (30% energy), from dairy (DM), beef (BM), or soy (SM), foods. Glucose and insulin were measured at baseline and 60, 120, 180 minutes. Results: 13 obese women participated. Glucose at 60 min was lower after DM than BM & SM, (6.36±0.53, 7.52±2.39 & 7.35±1.96 respectively, p<0.05 ). Return to baseline was delayed after DM (at 120min; 6.15±1.0, 5.42±1.0 & 5.22±0.51 p<0.05). There was no effect of meal on glucose AUC. Insulin was lower at 60 min for DM (DM 80.3±51.5, SM 102.9±59.6 & BM 114.9±57.2 p=0.02). Mean insulin:glucose ratio was 23% higher for BM (BM 8.82±0.93, DM 7.21±0.71, SM 7.30±0.64, p=0.02) . Conclusion: High in dairy protein meals produce a smaller, but more sustained, rise in postprandial glucose. Meals high in beef are a stronger stimulus for insulin secretion.
No evidence for metabolic adaptation in energy expenditure and serum leptin after surgically-induced weight loss with ajustable gastric banding.
Coupaye M, Bouillot JL, Coussieu C, Guy-Grand B, Basdevant A, Oppert JM, University Pierre-et-Marie Curie, Hotel-Dieu Hospital, Paris, France Aims: To assess changes in energy expenditure and serum leptin after surgically-induced weight loss in obese patients, taking into account body composition. Methods: In 36 obese women (age 27-58 y, BMI 34,1-68,5 kg/m 2 ), we measured immediately before and one year after adjustable silicone gastric banding (ASGB): resting metabolic rate (RMR) by indirect calorimetry (Deltatrac II, Datex), body composition by dual X-ray absorptiometry (Hologic QDR 2000) and serum leptin by RIA (Linco). Comparisons of means were performed by paired t-tests. Adjustments were performed using linear regression analyses. Results: One year after ASGB, there were significant decreases in weight (23.7±11.6 kg, p<0.001), fat mass (FM, 20.9±11.3 kg, p<0.0001), fat-free mass (FFM, 3.0±5.3 kg, p<0,01), RMR (298±309 kcal/d, p<0.0001), RMR/FFM ratio (3.9±5.8 kcal/kgFFM/d, p<0.001), leptin (24.0±18.4 ng/ml, p<0.0001), and leptin/FM ratio (0.21±0.29 ng/kgFM/ml, p<0.001). However, RMR adjusted for age, FM, and FFM, and leptin adjusted for age and FM were not significantly different before and after one-year follow-up. Conclusions: In this study, changes in RMR and serum leptin one year after ASGB were explained by changes in body composition. The data provide no evidence for a metabolic adaptation that would favor weight regain after surgicallyinduced weight loss.
T4:P4-025
T4:P4-026 T4:P4-027 T4:P4-028 Spanish orlistat support programme (Xeniplan®) enroled patients eating patterns changes and weight loss Cuatrecasas G., Nogués R., Albiol P., Berengüi E., Marin A., Pérez S., Rubio R. Centro Médico Teknon, Barcelona, Spain.
Aims: If patients enroled in Spanish orlistat patient support programme (Xeniplan®) weight loss is related to eating patterns changes caused by treatment. Methods: We took a sample of 81 patients (total Xeniplan® enroled patients 40.000) with BMI≥27 with obesity related comorbidities or BMI≥30 without. A telephone survey was conducted using a standard alimentary habits questionary. We determined good eating patterns consumption of fish, rice, vegetables, bread, dairy products and pasta RDA´s. Obtained results were analysed with SPSS. A regression was used to assess the influence of a good eating pattern on weight loss. Results: 64 patients (79%) changed their habits because weight loss programme. Almost all patients eat fish, dairy products, vegetables and fruit RDA´s. 68 patients (84%) eat rice RDA, 63 patients (78%) eat pasta RDA and, 57 patients (70%) eat bread RDA. In fact 54 patients (66%) have good eating patterns. Weigth loss is strongly influenced by good eating patterns (p<0.01) established during treatment. 74 patients (91%) declared to be satisfied or very satisfied with Xeniplan®. Conclusions: Xeniplan® the Spanish orlistat patient support progamme helps to establish a good eating patterns, which are closely associated with weight loss. 40 AM (waist, hip, limb circumferences, abdominal diameters, skin folds); total body and regional fat (multiple areas defined manually) by DXA. We determined by multiple regression the best equations for predicting VAT, using 2 AM ± 2 DXA measurements. Results: In women, AM were highly correlated to VAT (abdominal sagittal diameter + thigh proximal circumference +age+BMI; R=0,92); adjunction of DXA parameters slightly improved the prediction (R=0,95). In men, AM appeared less accurate (waist + thigh proximal circumferences; R=0,89), but adjunction of 2 specific DXA regions largely improved VAT prediction (R=0,95). We will provide the sensitivity (Se) and specificity (Sp) of the selected models for the prediction of VAT excess (>130 cm 2 ), and validation data of our and other previously published equations in another population. Conclusions: DXA regional fat measurements improve the prediction of VAT mostly in men. The use of markers of lower limb subcutaneous fat appears very usefull.
Does

Completion and weight loss results of the LighterLife Programme
Cox J S A, Lew J and Hewlett B LighterLife Ltd, Harlow, England Aims: To report on the progress of 2218 clients during 100 days on a commercial weight loss programme. Methods: LighterLife is a commercial weight loss programme exclusively for the obese which uses an abstinence model in parallel with Cognitive Behavioural Therapy (CBT). Clients were either self-referred or referred from their GP. They committed to attend the initial LighterLife weight loss phase of 100 days. This consisted of weekly two hour groups plus extra support during the first three weeks. Groups consisted of between 7 and 10 clients who were facilitated by a Lighterlife trained counsellor. Clients worked with CBT materials to help them explore the underlying causes of their eating behaviour and to develop a new way of living with food. Clients used a VLCD; ketones and weight were monitored on a weekly basis. Results: Of the 2218 starters, 71.9% (1594) completed 70 days and 57% (893) of those went on to complete 100 days with an average weight loss of 18.8 kgs (1.3 kgs pw ). Conclusions: Using the abstinence model to work with the addictive elements of obesity, along with CBT within small groups, the LighterLife Programme successfully helps clients achieve significant weight loss. T4:P4-030   T4:P4-031  T4:P4-032 Comparison between orlistat and sibutramine in obese patients with type 2 diabetes mellitus Derosa G, Ciccarelli L, Mugellini A, Boschi D, Ghelfi M and Fogari R University of Pavia, Pavia, Italy
T4:P4-029
Aims: The purpose of this study is to compare orlistat and sibutramine in obese patients with type 2 diabetes mellitus. Methods: We enrolled 26 obese subjects (BMI: 31.7 to 34.9 Kg/m 2 ) with type 2 diabetes mellitus. All subjects undertook standardised diet and no patients were taking oral hypoglycemic agents. We administered orlistat, 360 mg/day (n=12) or sibutramine, 10 mg/day (n=14) for 6 months. We assessed BMI, waist and hip circumference, glycated hemoglobin (HbA 1 c), Fasting and Postprandial Plasma Glucose (FPG and PPG). All variables were evaluated at baseline, and after 3 and 6 months for both treatment groups. Results: Side effects occurred in 4/12 in orlistat group and 4/14 in sibutramine group, but these were transient and all patients completed the study. BMI resulted significantly lower in both groups (p<0.01), and also HbA 1 c, FPG, and PPG were significantly lower in both groups (p<0.05). We observed also a decrease of waist and hip circumference in both groups, even if it was not significant. Conclusions: Orlistat and sibutramine were effective not only in weight loss, but also in glycemic control. However, longer term studies will be required to verify these potential benefits.
Effects of sibutramine in women with metabolic syndrome Dmitriev A, Kodolova J, Tarasov A, Bortnik S, Rolova E Ural State Medical Academy, Regional hospital No 1, Yekaterinburg, Russia.
Aims: to evaluate the efficacy, safety, and tolerability of sibutramine in the management of women with metabolic syndrome (MS) for a 3-month period. Methods: This is a double-blind, placebo-controlled study. Fifteen women with MS, aged 26-63 years were given a sibutramine (10 mg/day). Control group of 45 women with MS was given a placebo. The effects of sibutramine were assessed based on weight loss (WL), reduction in body mass index (BMI), abdominal and hip circumferences(AC and HC), AC/HC ratio, reported side effects, variation in arterial blood pressure and heart rate, metabolic profile (fasting glucose, total cholesterol and its fractions, triglycerides) and laboratory tests (hepatic functions). For statistical analysis Wilcoxon signed-rank test was used. Results: We observed a significant WL (by 9,2%, p=0,0004), reduction in BMI (by 10,8%, p=0,0004), AC (by 7,3%, p=0,0003), HC (by5,2%, p=0,0003) and AC/HC ratio (by2,3%, p=0,0004). The sibutramine group showed decrease in total cholesterol (by 7,4%, p=0,005), LDLcholesterol (by 12, 5%, p=0, 003) and triglyceride values (by 10,9%, p=0,03) . No significant difference in other values was found, and no side effects were observed during the treatment. The placebo group showed no significant changes in all values. Conclusions: These data confirmed the good efficacy, tolerability, and safety profiles of sibutramine for treatment of MS in women of different age.
Changes energy expenditure and appetite are not associated to changes in ghrelin or leptin during a short-term energy-restricted diet Doucet E, Pomerleau M. University of Ottawa, Ottawa, Canada Aims: To determine if acute changes in energy expenditure (EE) and appetite are associated to changes in leptin and ghrelin in response to a short-term energy restriction. Methods: 15 young adult male subjects (8 obese and 7 lean) were subjected to a 4-day energy restricted diet (-800 kcal/day). Resting and exercise EE, fasting and postprandial appetite scores, body weight and composition and serum ghrelin and leptin were sampled before and after the 4 days. Results: Body weight and composition remained stable during the intervention. Resting EE remained unchanged, while net exercise EE was significantly reduced (-5 %, p < 0.01). Appetite scores were increased by the end of the energy restriction (p < 0.05). As expected, serum leptin was higher in obese and was significantly reduced in both groups following the diet (-30%, p < 0.05). Ghrelin on the other hand, remained unchanged and was comparable in both groups. Finally, no significant associations were noted between changes in energy balance variables and changes in either leptin or ghrelin. Conclusions: Short-term changes in EE and appetite in response to an energy restricted diet do not seem to be under the control of ghrelin or leptin.
Comparison between orlistat and sibutramine in obese subjects with mild hypertension Derosa G, Mugellini A, Ciccarelli L, Boschi D, Ghelfi M and Fogari R University of Pavia, Pavia, Italy Aims: The purpose of this study is to compare orlistat and sibutramine in obese subjects with mild hypertension. Methods: We enrolled 34 obese subjects (BMI: 30.9 to 34.7 Kg/m 2 ) with mild hypertension (SBP/DBP > 140/90). We administered orlistat, 360 mg/day (n=16) or sibutramine, 10 mg/day (n=18) for 6 months . All subjects undertook standardised diet. We assessed BMI, waist and hip circumference, SBP, DBP, and heart rate. All variables were evaluated at baseline, and after 3 and 6 months for both treatment groups. Results: Side effects occurred in 6/16 in orlistat group and 2/18 in sibutramine group. BMI resulted significantly lower in both groups (p<0.01). SBP and DBP were significantly lower in orlistat group (p<0.05), but we did not observe any change on blood pressure and h eart rate in sibutramine group. Conclusions: Orlistat and sibutramine were effective in weight loss. Orlistat gave an improvement in blood pressure. Although sibutramine did not im prove blood pressure, any significant change was observed on blood pressure as well as on heart rate. Furthermore, side effects were lower in sibutramine group. However, longer term studies will be required to verify these potential benefits. Aims: We examine the effects of weight loss with orlistat on 10-year coronary heart disease (CHD) risk in clinical practice. Methods: Data of 6.184 patients included in the Obeso Study were evaluated, 5.815 with orlistat+diet (ORL) and 369 with diet alone (control group -CON-). 4.204 (72.3%) ORL and 276 (74.8%) CON ended six months of treatment. Ten-year CHD risk was assessed based on Framingham Heart Study equations. Results: At the start of treatment mean (±SEM) 10-year CHD risk was similar in both ORL group (9.1%±7.6%) and CON group (8.5%±7.9%). After six months mean weight loss in the patients who complete the study decreased by 11.8% ORL vs. 7.8% CON (p=0.0001). ORL patients had greater improvements than CON in total cholesterol (-26.4 vs. -12. 4 mg/dl), LDLcholesterol (-17.9 vs. -10.1 mg/dl) (both p=0.0001), SBP (-6.4 vs. -5.5 mmHg), DBP (-4.1 vs. -3.1 mmHg) (both p=ns). ORL six months treatment was associated with greater reduction in 10-year CHD risk: -18.2% (-2.1± 3%), compared with CON: -6.4% (-1.2 ± 2.8%) (p=0.0001). Conclusions: Six months weight loss with orlistat treatment almost triple the reduction of the 10-year CHD risk compared with diet alone in clinical practice. Children in the intervention group participated in six 1-hour skill based fun type physical activity sessions per day, moderate dietary restriction and four weekly educational sessions. All children were assessed for body mass, stature, % body fat, waist circumference, blood pressure, aerobic fitness, and global self worth. Results: During the six-week programme highly significant (P<0.001) improvements were achieved in all variables by the intervention group compared to the comparison groups. Conclusions: This study shows that, at least in the short term, children's residential programmes are one form of efficacious treatment in a range of intervention treatments needed to tackle the growing global epidemic of obesity.
Sports skills of overweight and obese children can be improved during an intensiveskill based fun type physical activity programme. Gately PJ, Cooke CB, Holden S. and Gray M. Leeds Metropolitan University, Leeds, England.
Aims: To assess if a skill based fun type physical activity programme can improve sports skills in overweight and obese children. Methods: Eighty children (BMI 33.59±6.38 kg.m 2 , aged 13.91±1.96 years) were enrolled on a six-week residential weight loss camp. Children participated in six 1-hour skill based fun type physical activity sessions per day, with a focus on improving sports skills and competence. In addition, the camp involved moderate dietary restriction and four weekly educational sessions. All children were assessed for 6 sports skills (badminton serve, basketball shot, soccer dribble, volleyball volley, hockey shot, tennis ball throw). Results: During the six-week camp highly significant (P<0.001) (Wilcox signed ranks test) improvements were achieved in all sports skills during the intervention. Conclusions: This study shows that, a skill based fun type physical activity programme can improve children's sports skills. It is hoped that such positive changes will contribute to the children's ability to continue to participate in sport, exercise and physical activity following the camp programme.
Conclusion: PA and VO 2 max are correlated in obese adolescents. The reduction in abdominal fat massseems to be a key factor in the improvement of physicalactivity levels. Aim: To assess the efficacy of an interactive weight loss program (IWLP) developed for general practitioners to manage obese/overweight patients. Methods: The IWLP is aimed at reduction of caloric intake and increase in physical activity in an individualised manner to achieve therapeutic weight loss by introducing stepwise lifestyle changes accepted and initiated by the patient. Obese patients presenting for usual consultation were offered treatment by IWLP. Eating habits and physical activity were assessed by daily dietary diary, and pedometer recorded steps, respectively. Progress was monitored by anthropometric measurements. Data including average number of steps expressed as percentage were normalised to initial values and were plotted against time. Results: Of 119 adults 70 consented to the IWLP, of whom 17 were actively treated (IWLP), 9 on maintenance program (MP), 44 dropped out.
The strongest correlations were found between the mean number of steps and the slope of the body mass index (r=0.85) and weight (r=0.91). Conclusion: Obesity can successfully be treated long term by a program tailored to each individual. Patient acceptance of the preventive nature of weight loss needs to be targeted more effectively.
Citizen Health Care: An EU programme for integrated, home-entred management for patients with obesity Goulis DG, Tsimtsiou Z, Giaglis GD, Kontopoulos M, Moraiti A, Kita M, Maglaveras N, Avramides A. Dept of Endocrinology, Hippocration Hospital, Thessaloniki, Greece Improved quality of life, citizen involvement via education, cost effective care delivery supported by telecare systems and health care harmonization in diverse cultural environments are considered crucial parameters in any modern chronic disease management attempt. Citizen Health Care (CHS) is a European Union programme (IST 1999-3369) with Hewlett-Packard (ITA), Aristotle University of Thessaloniki (GRE), University of Regensburg (GER), American Medical Development Inc (USA), Card-Guard (ISR) and University of Genoa (ITA) as major partners. Main CHS aims include (i) development of telemedicine services for home care that will ensure proper disease management, (ii) integration of medical devices and telecare systems, (iii) provision with better and more efficient communication between health care providers and citizens, (iv) active patient involvement in the health care process and (v) increased awareness of decision makers on benefits of using information technologies in health care delivery and quality through evidence based medicine. The CHS project will use obesity, diabetes mellitus and congestive heart failure as models of chronic disease. It will conduct three randomised clinical trials and it will be completed in June 2003.
Citizen Health Care: A randomized control-matched trial for home-centred management in obese patients
Goulis DG, Giaglis GD, Tsimtsiou Z, Kontopoulos M, Moraiti A, Kita M, Maglaveras N, Avramides A. Dept of Endocrinology, Hippocration Hospital, Thessaloniki, Greece Aims: A randomized, controlled-matched study was conducted for the needs of Citizen Health Care (CHS), a European Union programme (IST 1999-3369) , in order to test the hypothesis that high quality management of obese patients through the use of telecommunication will lead to a change of short-term disease outcome as well as an improvement to health-related quality of life (QoL). Methods: 120 patients were randomized to receive either standard hospital-centered management or CHS homecentred management, through a computerized contact center. Body weight and blood pressure were measured by electronic microdevices. Communication with contact center was achieved through a variety of telecommunication means, namely regular phone, WAP phone and Internet. QoL was assessed by IQOLA 1.1, EQ-5D and OAS questionnaires. Results: There was a significant reduction in body weight and BMI and a significant increase in QoL scores in the CHS group as compared to control group (p<0.05). Conclusions: Intense, home-centred management proves to be an effective and reliable method for weight reduction and QoL increase for overweight and obese patients.
INTRAGASTRIC BALLOON FOR WEIGHT REDUCTION: DOUBLE BLIND PROSPECTIVE RANDOMIZED CROSS OVER STUDY (BIB VsPLACEBO)
Genco A, Raparelli L, Cipriano M, Basso MS, Bacci V, Cuzzolaro M, Baglio G, Materia A, Basso N University of Rome "La Sapienza", Italy Aims: Aim of this study was to assess th e real effect o f th e intragastric balloon in consideration of the results of a double blind prospective study. Methods : From Oct. 2000toJan. 2002 patients were enrolled in a double blind prospective cross over study. 8 Pts (Group A) were treated with BIB for 3 months and th en consecutively with placebo for other 3 months. 8 pts (Group B) were tre ated with placebo for 3 months and afterward with BIB for the same time. Each pt was evaluated for: preand post-operative weight, post-operative symptoms (nausea, vomiting, pain), endoscopic findings, complications. Results: No pt w as dropped out and a detailed follow-up was available for all 16 patients. Mean weight loss with BIB was 14.3 kg in Group A and 14.5 Kg in Group B. In the placebo period the mean weight loss was 3.6 Kg in Group A and 2.3 in Group B. The series showed a statistically significant difference in weight loss when treated with BIB compared to the placebo Group.
Conclusions:
The study suggests that the effects of BIB on weight loss are not related to placebo effect. However a prospective study with more pts enrolled must be considered.
Influence od Diet Habits on Weight Loss of Overweight and Obese Women with Dyslipidemia
Gudelj J., Gajic I., Bozic Z., Separevic N. Institute of Public Health of Serbia, Belgrade, Serbia Aims: Determine influence of diet habits on weight loss of overweight and obese women with dyslipidemia. Methods: Data were obtained from 50 randomly selected women, aged 25-70y. Usual dietary intake was assessed with a FFQ. Detailed medical history data were obtained. Height, weight, waist and hip circumferences were measured. Total serum cholesterol (Hol) and triglyceride (TG) levels were analyzed. Association of diagnosed dyslipidemia with dietary intake was assessed. The focus of nutritional therapy included individual instructions to help patients reduce total fat, saturated fat and cholesterol intakes and to increase fruit, vegetable and fiber consumption. Results: Baseline data showed that 8% of women ate 3 times/d, 34% once and 60% had 2 meals/d. After two months follow-up FFQ data showed significant improvement regarding number of meals and food selection. Anthropometric measurements showed statistically significant reduction of BMI, WC and HC values. Levels of total Hol and TG decreased in all patients. Conclusions: Nutritional therapy is recommended as initial treatment for dyslipidemia, but dietary change and maintenance must be sustained over the course of many years to decrease the risk of long-term complications.
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Role of Orlistat for changing nutritional habits in patients with Obesity and Dyslipidemias
Handjiev Sv, Ikonomova K, Handjieva T* Transport Medical Institute, Sofia, Bulgaria *Medical University, Sofia, Bulgaria Aims: To investigate the influence Orlistat on metabolic indexes and nutritional habits in patients with obesity and dyslipidemia. Methods: Forty-three women with obesity and dyslipidemias were examined. Anthropometric and biochemical laboratory methods were applied. Results: The initial mean values for anthropometric and metabolic indexes were as follows: body mass -100,2 kg., height -166 sm., BMI -36,4, body fat mass -33%, waist to hip ratio -0,91, total cholesterol -7,28 mmol/l, HDL-cholesterol -0,94 mmol/l, LDLcholesterol -4,32 mmol/l, triglycerides -3,42 mmol/l. Patients kept diet for four months parallel with Orlistat therapy during the first three months. Orlistat was administrated twice daily (lunch and supper) 120 mg per dose. The obtained results showed gradually reduction of body mass, BMI, body fat mass, waist to hip ratio, total cholesterol, LDL-cholesterol and triglycerides. We found a favorable effect on atherogenic indexes. During the four months of observation we found a significant decrease in fat consumption (respectively calories). Conclusions: The role of Orlistat in the balancing of diet especially with respect to fat consumption was pointed out. Favourable changes in the nutritional habits of the patients after the end of therapy were emphasised. Results: Mean weight (wt) loss from baseline was greater with s than with p at wk 16 (9.0 kg vs. 4.9 kg,p<0.001). At wk 48, a significant wt reduction was revealed in both groups of patients. At wk 16, the treatment with s, in contrast to p, resulted in significant decreases of depression score, disinhibition score, and hunger score as well as in significant increase of restraint score. The changes in all three items of the TFEQ between baseline and wk 16 were significantly different, if the s and p groups were compared. Treatmentinduced changes in depression score and in the items of TFEQ remained significant if controlled for body wt decrease. Conclusion: Sibutramine exerted a positive influence on both depression score and eating behaviour of obese women Ambulant Long-Term Treatment (12 Month) of Obesity due to National Treatment Guidelines: 6 Month Results Hebisch S, Kulassek B and Litz A, Adipositas-Praxis Dr Hebisch, Bottrop, Germany Aims: The efficacy of an ambulant interdisciplinary treatment program (12month, follow-up till 24 month) for adults based on behavioral, nutritional and exercise interventions has to be proved. Methods: Monocenter intervention study. 23 patients (5 male, 18 female, age 47.6+10.6 years (SD)) in two groups. After a standardized medical, psychological and nutritional evaluation all patients got 1hour/2 weeks nutritional and behavioral therapy as well as 2hours/week exercise (low-impact-aerobic, aqua-aerobic, walking). Results: 18 of 23 patients (78%) took part regularly during the first 6 month. Their body-weight decreased from 98.6+20.7 to 92.9+19.0 (3month) and 89.4+16.9kg (6month), their body-mass-index from 35.6+6.3 to 33.6+5.8 and 32.4+5.1, their waist-hip-ratio from 0.94+0.05 to 0.86+0.07 and 0.85+0.08 and their body fat from 39.8+4.5 to 38.5+4.9 and 37.5+4.8%. No adverse events were observed. Conclusions: It could be shown, that an ambulant obesitytreatment based on psychological, nutritional and exercise interventions is able to achieve significant weight-reductions (9.2+6.3 kg) in 78% of all patients after 6 month. The study is ongoing. Further results will be reported. Aim: Examine the effect of an arachidonic acid (AA) supplement on adiponectin gene expression in humans. Methods: Two intervention periods of 3 weeks separated by a washout period of 2 weeks in a placebo-controlled, randomized, and cross-over design. Subjects consumed their usual isoenergetic diet combined with Corn/Soy oil (placebo) or AA (0.8 g/day) oil capsules. Fasting adiponectin levels were measured before and after each intervention in eight type 2 diabetic patients. Subcutaneous abdominal fat biopsies were taken before and after the AA intervention and gene expression of adiponectin was measured by quantitative real-time RT-PCR. Results: Fasting adiponectin levels did not change significantly between interventions. Adiponectin gene expression increased significantly after the AA treatment (P < 0.05). Conclusion: AA may play a role in the regulation of adipocyte-related gene expression encoding protein that may be involved in the control of glucose homeostasis.
Effects of a rehabilitation course on perceived health in obese subjects
Effect of plant sterol containing product on lipid profile in healthy, male subjects with mild hyperlidaemia Johnstone AM, Rowe A, May S Rowett Research Institute, Aberdeen, UK Aims: Risk of CHD is directly related to blood cholesterol levels. We investigated whether the consumption of cheese product containing wheatgerm oil (a natural source of plant sterols, PUFA and Vitamin E), reduced cholesterol in mildly hypercholesterolaemic, male subjects. Methods: Twenty-eight, male volunteers (age 50 -66 y, BMI 23-32 Kg/m 2 ) participated in a three-week intervention study, to investigate the effects of 70 g/d of a hard cheddar type cheese, made with skimmed milk and a wheatgerm oil blend, on plasma cholesterol levels. Subjects were assigned, in a paired design, to one of two groups: 'control' (conventional vegetable oils) or 'intervention' group (wheatgerm oil blend). Venous blood was collected at week 0, 1, 2 & 3. Results: On average, from week 0 to week 3, total cholesterol significantly decreased by 5.7% (0.39 mmol/L) in the intervention group (P=0.022), with no change seen in the control group (P=0.854). Within both groups, there was a favourable change in lipid profile (LDL:HDL ratio, P<0.05). Conclusions: These preliminary data suggest that daily consumption of a cheese containing a specific wheatgerm/vegetable oil blend significantly reduced both total and LDL cholesterol in mildly hypercholesterolaemic male subjects, within three weeks.
The changes in radial artery pulse waves by auricular stomach point detection after rapid weight loss Ikezono E, Ikezono T, Takahashi G New Obesity Research, Tokyo, Japan Aims: Non-invasive digital analysis of radial pulse waves were performed following the detection of auricular acupuncture stomach point, before and after the rapid weightloss of 18±5 Kg in 5.7±1.8 months. Methods: Four male and threefemale with average BMI=31.6±1.3 were treated by low caloric diet therapy of 1000Kcal withen hancing satiation by earacupuncture of stomach point. Acupuncture points in auriclewere detected using acupuncture detecting apparatus.
Radial artery pressure waves were measured by tonometry and digital analysis such as systolic pressure, pulse pressure, peak to peak interval, initial upstroke and dp/dt of the first wave were performed. Results: 7 patients lost weight 14.3-28.9 Kg in 4-9 months. At the beginning of the treatment, radial artery tonometry revealed increase in in systolic pressure from 114.8±9.8 mmHg to 126.1±10.5 mmHg (p=0.0028), peak to interval decreased 971.9±142.2 msecto 937.7±120.8 msec (p=0.0232), following the detectionpf the stomach point. On the contrary afterrapid weight loss, these changes were not significant.
Conclusions:
The changes in radial artery pulse waves by stomach point detection seems to correlate with the speed of weight loss. Results: The analysis of a 12-month program showed the comprehensive approach to the therapy of obesity to have a statistically significant effect on weight control. The average weight loss was 14.5% of the baseline weight. Besides the weight reduction, the levels of blood lipids were lowered, the glucose metabolism improved, and the blood pressure levels dropped by 5%. The subjects expressed satisfaction with the program and the results achieved. Conclusions: Xenimap, the Croatian weight loss program is an efficient and reliable mode of obesity management. Aims: The aim of this study was to gain insight into the relationship between eating behavior and weight loss failure long-term after Laparoscopic Adjustable Gastric Banding (LAGB), which may lead to the development of interventions to further improve outcome. Methods: 109 patients with mean postoperative follow-up duration of 42 (range 25 -68) months filled out questionnaires to assess eating behavior. Results: Multiple logistic regression analyses showed that, after controlling for the influence of demographic variables, more binge eating problems and lower dietary restraint were associated with failed weight loss after LAGB. Fat intake, emotional-, and external -eating patterns (i.e., eating in response to negative emotions or eating cues) were not associated with failed weight loss, though were highly associated with binge eating problems. Conclusions: Our analyses suggest that binge eating is a main factor in long-term failed weight loss after surgery for severe obesity. Thus, the identification and treatment of postoperative binge eating problems appear critical to improve long-term outcome after LAGB. Aims: Stable personality characteristics are assumed to affect health-related behaviors and, thus, a variety of health outcomes. Our aim was to examine prospectively whether personality predicts weight loss after bariatric surgery, and, more specifically, whether personality becomes a stronger predictor of weight loss as postoperative time increases. Methods: 168 patients (143 f, 25 m, age 18-58, mean 37) completed the NPV, a Dutch personality questionnaire, on average 1,5 years before the operation. Results: Multilevel regression analyses showed that none of the personality variables were associated with weight outcome, but a lower educational level, being female, and a higher starting BMI were associated with more weight loss. By allowing individual differences in weight change patterns, higher preoperative hostility was associated with less weight loss more than two years, but not short-term, after surgery. Conclusions: Because personality is not an important predictor of weight outcome, personality scores should not be used as a selection criterion for bariatric surgery. However, individuals with high preoperative hostility may need special attention on the long-term after surgery. Objective: To evaluate a 1-year treatment program using regional clinical guidelines for treatment of obesity. Methods: A total of 28 − 23 obese adults (8 type 2 diabetics) visited the clinic every 14:th day. At each visit a dietician gave dietary counselling. Total daily energy expenditure (TDEE) was calculated from estimated basal metabolic rate corrected for physical activity (mild or moderate). The recommended diet was based on 70% of TDEE and in accordance with national guidelines. Individuals were at visits also encouraged to increase physical activity. Results: Of the 14 completers (11 , 4 type 2 diabetics) 7 were treated with Orlistat or Sibutramil for at least 6 months. The mean weight loss was 5,9 kg and BMI was reduced from 39,5 kg/m 2 to 37,5 kg/m 2 . 5 participants achieved a weight loss of 5% or more. Conclusions: Our findings indicate that in some subjects intensive dietary counselling with optional multifactor intervention including drugs can be a successful treatment in obesity. However, the high drop out rate demonstrates a need for alternative treatment programs. Aim: To examine the target score of visceral fat area (VFA) for an improvement of multiple risk factor clustering in Japanese patients with newly diagnosed impaired glucose tolerance and type 2 diabetes. Methods: Risk factor was defined as following; resting systolic blood pressure ≥140mmHg and/or diastolic blood pressure ≥ 90mmHg, total cholesterol ≥ 220mg/dl, triglyceride ≥ 150 mg/dl, HDL-cholesterol < 40mg/dl,and fasting glucose ≥ 126mg/dl and/or HOMA-IR ≥ 1.6. One year diet and exercise therapy was performed in both groups of patients (N=54) Aims: To relate clothing size to waist circumference, body mass index and to the risks of ischaemic heart disease, hypertension and diabetes mellitus. Methods: Cross-sectional study in a subsample of 201 men and 161 women aged 27-67 years from the Glasgow monitoring coronary risk factor (MONICA) survey. Results: Clothing size correlated (P<0.001) linearly with indices of adiposity (waist, BMI), while height had minimal influence. Compared to men with trouser size below <36 (UK / US = 97 European) or women with dress size below <16 (UK, = 18 US or 48 European), the age and smoking adjusted odds ratios for the risk of having at least one major health problem (ischaemic heart disease, hypertension or diabetes mellitus) were 3.94 (95% CI: 1.8 to 8.3) in men, and 7.0 (95% CI: 2.5 to 19.4) in women, who had trouser size >38 or women with dress size >18 respectively. Conclusions: People with large clothing size are at increased risk of ischaemic heart disease, hypertension and diabetes mellitus. Larger trouser size of >38 (UK and US) or >97 (European) in men or larger dress size of >18 (UK) or >16 (US) or >48 (European) in women could be targeted to promote self-awareness of increased health risks.
Effects of an intensive treatment program in obesity
Short-term weight intervention using very-low-fat, high carbohydrate meal replacements Lee BG, M.D., Kim KK, M.D, Lee KR, M.D., Park MH PHD Bariatric Medicine, Charm Clinic, Seoul, Korea reduction, the use of very-low-fat, high carbohydrate (VLF, high-CHO) meal replacements recently has gained popularity in Korea. This study investigated the efficacy of VLF, high-CHO meal replacements. Methods: Participants were 54 obese women (BMI>25, age 25-35) and were divided into two groups: Group A, the experimental group, took meal replacements for breakfast and dinner. Group B, the control group, received instruction concerning exercises and diets. The duration of the experiment was 6 weeks. Results: 35 out of 54 finished the 6-week experiments. Group A took 1042.61±179.73 kcal/day, and group B took 1313.49± 308.07 kcal/day for 6 weeks. There is a significant difference between two groups. Group A showed a significant reduction in weight (-3.84±1.97kg, 5.39%), the % body fat (-1.42±2.20%). Group B also showed a significant reduction in weight (-3.39± 2.25 kg, 4.64%). However, there is no significant differences in changes of their weight and body fat between two groups. Conclusions: From these results, Korean women who took VLF, high-CHO meal replacements twice a day for six weeks ate fewer calories, lost their weight, and lost their body fat.
Aims: Among the obese and those interested in weight
Effect of red pepper on substrate oxidation and weight maintanance after modest body weight loss in humans Lejeune M.P.G.M., Kovacs E.M.R., Westerterp-Plantenga M.S. Maastricht University, Maastricht, The Netherlands.
Aims: To investigate whether red pepper (RP) may improve weight maintenance (WM) by limiting body mass (BM) regain after BM loss of 5 to 10%. Methods: In this randomized double blind placebo controlled study 97 moderately overweight subjects were randomly assigned to a RP and a placebo group. 4-wk very low energy diet (VLED) was followed by a 3 months WM period. BM was measured before and after VLED and after 3 months WM. Results: The mean (±sd) BM loss during VLED was 6.6 (±2.0) kg (= 7.8 (±1.9) % of initial body mass), and was not different between the groups. During WM mean %regain in the RP group was not significantly different compared to placebo (32.1±41.3% vs 19.7±7.8%; P=0.23). Respiratory quotient was significantly less increased during WM in the RP group compared to placebo (0.04±0.06 vs 0.07±0.05; P<0.05), indicating a relatively more sustained fat oxidation. Conclusions: RP treatment showed a sustained fat oxidation during WM compared to placebo, however this had no limiting effect on 3 months WM after modest BM loss. Aim: To examine the effect of including or excluding red meat, as part of a weight reducing diet, on plasma lipids and weight loss. Methods: One hundred and twenty-two overweight men, aged 18 to 55 years, mean BMI 30.8 + 3.6 kg/m 2 , were recruited and participated in a randomised controlled weight management trial. Results: Ninety-one men completed the 12-week weight loss period. No significant difference in weight loss was observed according to treatment group -4.1 + 3.7 kg (meat) vs -5.0 + 3.2 kg (no meat) p=0.2. No significant between group differences (meat vs no meat respectively) were seen in the changes, from baseline to week 12, in plasma lipids; total cholesterol -0.3 + 0.4 mmol vs -0.3 + 0.6 mmol p=0.7, LDL cholesterol -0.1 + 0.4 mmol vs -0.2 + 0.5 mmol p=0.5, HDL cholesterol -0.002 + 0.1 mmol vs 0.004 + 0.1 mmol p=0.5 and triglycerides -0.1 + 0.7 mmol vs -0.2 + 0.7 mmol p=0.6. Conclusion: This study achieved a similar weight loss to other dietary interventions in the overweight. No benefit was seen in excluding red meat in terms of plasma lipids and weight change over 12 weeks.
These findings reinforce the promotion of the principles of healthy eating on which any weight reducing diet should be based.
The effects of weight reduction on physical fitness, body composition and associated variables in obese children Liao YY, Chin HML Tri-service General Hospital, Taipei, Taiwan Aims: To investigate the effects of weight loss on physical fitness and related variables in a group of obese children. Methods: An 8-weeks summer weight management program was applied for forty Chinese obese children with mean BMI 28.9±4.3. In the beginning and the end of this program, health-related physical fitness tests (for cardio respiratory fitness, muscular strength and physical flexibility), body composition and blood pressure were measured, and fasting blood samples were also drawn to determine insulin levels and associated metabolic indices. Paired-t test was used for comparison of data obtained from those who lost 5% of initial weight. Results: The body mass index, body fat, blood pressure and insulin levels were significantly decreased, and muscular strength improved; however, cardio respiratory fitness remained unchanged. Conclusions: Further study is needed to determine the most beneficial weight control program for children in cardio respiratory fitness enhancement.
One-year follow-up of completers of a 4-year long intervention study of obese subjects. Löndahl M, Katzman P, Nilsson A, Påhlsson A, Klingström S, Kjellström T Department of Internal Medicine, Helsingborg Hospital, Helsingborg, Sweden Aims: The aim of this study was to evaluate weightmaintenance at one-year follow up in patients completing the four year long Xendos-study at the Helsingborg centre. Methods: Of 148 patients randomised in the Xendos study at the centre in 1997 64 completed the study 4 years later. 58 patients (38 treated with orlistat and lifestyle changes and 20 with placebo and lifestyle changes) admitted at the one-year follow up visit. The weight was 111,6 kg vs. 110,5 kg (orlistat vs. placebo) in the beginning of the Xendos-study in 1997 and 106,9 kg vs. 107,4 kg at the end of the study in 2001. 36,8% vs. 35,0% achieved 5% weight loss or more. Results: The weight at the one-year follow-up was 111,4 kg vs. 107,0 kg. 21,1% vs. 40,0% was 5%-responders. Conclusions: Since obesity is a chronic disease weight gain usually recur when treatment is discontinued. In our material the patients gained 2,6% in weight during the follow-up year. The weight gain was significantly greater in the orlistat group. This may partly be due to selection of dropouts during the Xendos-study, but may also implicate that disruption of pharmacological treatment in absence of continued regular contact with an obesity team results in weight gain. Aims: To evaluate the changes in anthropometric parameters in obese subjects treated with bariatric surgery. Methods: We have studied 35 obese subjects (mean weight 147 kg, mean BMI 54) in whom anthropometric parameters were evaluated before and after surgery (1, 6, 12 and 24 months). Results: In 16 subjects due to stability of the anthropometric parameters gastric by pass was needed to obtained weigh reduction. In addition, in 4 obese subjects gastric by pass was used due to secondary effects of bariatric surgery. After 24 months in the by pass group a significant mean reduction of 74 kg and a mean BMI of 28 was obtained. Conclusion: In 50 % of obese subjects treated with bariatric surgery gastric by pass was needed to obtained significant reduction in anthropometric parameters of morbid obese subjects.
Nutritional status of severe obese individuals undergoing gastric bypass surgery (GBP)
Moizé V, Morínigo R, López MC, Gomis R, Vidal J. Obesity Unit, Hospital Clinic Universitari. Barcelona, Spain.
Nutritional deficiencies may occur in obese patients following GBP. However, their nutritional status prior to surgery has seldom been reported. Aim: To evaluate the baseline nutritional status of severe obese individuals (SOb) undergoing GBP. Methods: Total protein, albumin, prealbumin, ferritin, iron, phosphorous, selenium, chrome, magnesium, zinc, vitamin B 12 , C, A, B 6 and folate were measured in 29 SOb (BMI: 50.7 + 6.2 kgm 2 ) and 23 normal weight non-diabetic controls matched for age, gender, and height. Non-parametrics analysis (Mann-Whitney-U) was used for comparison. Results: lower serum levels of albumin, zinc, and prealbumin were found in obese individuals (p=0.003, p= 0.011, and p=0.001 respectively) compared to controls. Iron levels also tended to be lower in SOb (p=.06) although ferritin levels were not. Among SOb the frequency of low plasma levels of magnesium, iron, and folate, compared with controls were 17%, 27.6%, and 20% respectively. Conclusion: Our data suggest that nutritional deficiencies are already present in SOb even before surgery. This should be taken into account to minimize the impact of caloric restriction following GBP on their nutritional status.
Orlistat efficacy on weight, waist and co-morbidities vs. diet alone in clinical practice. The Obeso study. Moreno B., Formiguera X., Genis M., Azpeitia A. and the Obeso Study Group (1342 investigators) Hospital Gregorio Marañón. Madrid. Spain.
Aims: First observational 6-mo. study to assess the effect of orlistat (ORL) in clinical practice on body weight, waist and obesity-related co-morbidities are presented. Methods: 6.184 patients (1.682 men, 4.491 women) were included (mean BMI 34.9). 5.815 were on ORL+hypocaloric diet, 369 were on hypocaloric diet alone (control group -CON-). Results:Patients who complete 6-mo. (73%) mean weight loss was 11.8% ORL vs.7.8% CON (p=0.0001). ORL patients who lost ≥ 5% at 1-mo. (responder -RE-) achieved mean weight loss at 6-mo. of 14.5%. 6-mo. weight loss ≥ 5% was achieved 88% ORL vs. 64% CON; and ≥ 10% by 60% ORL vs. 33% CON (p=0.001), (82% more ORL vs. CON). Mean waist reduction were 11.7 cm. ORL (16.4 cm. RE) vs. 7 cm. CON (men) and 9.3 cm. ORL (13.7 cm. RE) vs. 7.1 cm. CON (women) (p=0.0001). Greater improvements were in ORL group than CON group: total cholesterol (9.9 vs.3.9%), LDL-cholesterol (8.7 vs. 2.7%), fasting glucose (6.3 vs. 3.4%), DBP (4.1 vs. 2.9%). Adverse effects were similar in ORL vs. CON except for those (gastro-intestinal) due to orlistat mechanism of action. Conclusions: Orlistat treatment improves weight and waist reduction and obesity-related co-morbidities more than diet alone in clinical practice. Aims: 1) To determine the intra-individual day-to-day variation of a new BIA machine for measuring total-body water (TBW), total fat mass (TFM) and total fat-free mass (TFFM i.e. water, muscles, internal organs, bone), and 2) compare measurements of TFM and TFFM made using BIA and dual-energy X-ray absorptiometry (DEXA), in obese subjects. Methods: TBW, TFM and TFFM were measured (in triplicate) using the IMP5 BIA (IMP5, Impedimed Pty Ltd, Brisbane, Australia), on two consecutive mornings after an overnight fast, in 12 subjects [mean (±SD) age 52±11 yrs, BMI 30.8±4.1 kg/m 2 ]. TBW, TFM and TFFM were computed using the IMP5 direct algorithm for obese individuals, as well as the IMP5 'offline' general algorithm. In addition, 60 obese subjects (BMI 34.8±4.3 kg/ m 2 ) had TFM and TFFM measured on two separate occasions using IMP5 BIA and DEXA (Norland densitometer XR36; Wisconsin, USA). Results: Intra-individual day-to-day variation was smaller using the IMP5 'offline' general algorithm as compared to the algorithm for obese individuals (0.9 vs 1.2% for TBW, 1.8 vs 1.9% for TFM, 0.9 vs 1.2% TFFM). TFM (BIA 40.4 vs DEXA 40.7 kg, p>0.1) and TFFM (BIA 57.6 vs DEXA 56.2 kg, p>0.1) as measured by the two methods were similar. Conclusion: The IMP5 BIA machine is reproducible, and measurements of TFM and TFFM using the 'offline' general algorithm are comparable to DEXA, in obese subjects. This test evaluates the following areas: health perception, depression, anxiety, eating disorders, concern about weight and major factors of stress. Drop-out was defined if patients failed to attend the visit at 3 or 6 month after the start of weight reducing therapy. 10 patients were lost to follow-up. Results: Statistical differences were observed in the concern about physical appearance (70% lost vs 55% compliant patients) and in the positivity to stress agents (70% lost vs 37% compliant patients). On the other hand, no differences about health perception, depression, anxiety, and eating disorders were seen between compliant and lost to follow-up patients.
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Conclusions: These preliminary data suggest that worries about physical appearance and stress agents could be associated to the risk of drop-out.
Weight loss and maintenance with sibutramine in subjects who regained weight after bariatric surgery Muratori F, Vignati F and G. Di Sacco U.O. di Endocrinologia, Niguarda Hospital, Milan, Italy Aims: Evaluation of the effects of sibutramine on weight loss and maintenance in patients who regained weight after bariatric surgery. Methods: Sibutramine(sib) was administered continuously (10 or 15 mg daily) for 8 -12 mos in 6 female subjects (aged 28-63 yrs, mean 42.1) who regained weight after bariatric surgery (5 adjustable gastric banding, 1 gastroplasty). After, sib was administered (10-15 mg daily) cyclically (1 cycle = 2 mos) when the subject regained weight. Treatment was associated to dietary and behaviour counselling. Results: At the end of the continuous sib treatment all the pts lost weight (mean 13.4±3.9 kg) and mean BMI decreased from 37.62±3.15 to 32.42±2.88. At the time: 2 pts maintained weight 9 and 10 mos after sib discontinuation. 4 pts underwent sib cyclic treatment. The first cycle started 2-6 mos after the end of the continuous sib treatment (mean 4 mos) and the weight regain was 2-4 kg. Pts underwent 1-2 cycles. All the pts lost weight coming back to the weight levels achieved at the end of sib continuous treatment.
Conclusions: This study show the possible role of sibutramine in the management of patients who regained weight after bariatric surgery. Aims: To examine the relationship between insulin sensitivity and hormone replacement therapy in overweight and obese postmenopausal women. Methods: 25 postmenopausal women, 15 under HRT (HRT group) and 10 controls (CT), were evaluated through bioelectrical impedance; oral glucose tolerance test; indirect calorimetry to assess oxidative and non-oxidative glucose disposal and euglycemic hyperinsulinemic clamp (insulin infusion of 40mU/m 2 .min for 2 hours). Results: Waist circumference was higher in CT (p =0.05). Insulin sensitivity, M value (mol/kg.min)=21.8±8.4 for HRT and 21.1±8.5 for CT, and the oxidative and non oxidative glucose disposal were similar in both groups. Hormone replacement did not influence plasma lipids, or fasting plasma glucose. Glucose area under the OGTT curve was higher in CT (1083±115 vs 971±120 mmol/l.2h; p =0.04). Fasting plasma insulin and insulin area under the OGTT curve tended to be higher in CT (p =0.08). M value was inversely associated with BMI, body fat % and with waist circumference. Conclusions: Although HRT did not improve the insulin resistance associated with obesity and waist circumference, HRT improved the response to glucose load. Aims: This study investigated the effects of tea catechins intake on body fat and serum malondialdehyde-low density lipoprotein (MDA-LDL). Methods: Japanese male subjects (BMI: 24.9±0.3kg/m 2 ) ingested a beverage containing 690mg (690mg group, n=17) or 20mg (20mg group, n=18) tea catechins daily for 12weeks. Anthropometric parameters, abdominal fat levels (estimated by CT scan) and biochemical blood parameters were measured. Results: BMI, waist and abdominal fat levels were significantly lower in the 690mg group compared to the 20mg group. Changes in body fat parameters and changes in MDA-LDL were correlated at 12weeks. Conclusion: Daily intake of tea catechins reduced abdominal fat. This reduction might be related to the anti-oxidant effect of tea catechins. Tea catechins might be useful in the prevention and treatment of obesity.
Patient satisfaction in the orlistat weight management programmes
Noack, P. Bramich, K, Frogley, R. F.Hoffmann-La Roche, Basel, Switzerland Aims: Orlistat weight management programmes (WMPs) are now available in over 50 countries for health care professionals to use with their patients. This study investigated weight loss, patient satisfaction with weight loss and patient compliance in patients enrolled in the New Zealand and Australian WMPs. Methods: The orlistat WMPs aim to help patients set and reach realistic goals for weight loss, while modifying their dietary in take and behaviour in the long-term. The programmes are individually tailored to help patients achieve their weight loss goals by healthy eating, physical activity, behaviour modification and pharmacotherapy. Patients were asked questions about weight loss, compliance and satisfaction during each contact over a 3 month period. Results: Over 22,000 patients were enrolled in the Australian and New Zealand orlistat WMPs during a 3 month period. More than 80% of enrolees were female and average body mass index (BMI) at enrolment was 33.1 kg/m2. Patients were compliant with their medication, taking on average 2.5 capsules per day. Mean weight loss after 3 months was 8.4 kg. On average, 52% of patients were extremely or very satisfied with their weight loss, a further 31% were some what satisfied, and only 18% were not satisfied with their weight loss. Conclusions: Based on these data, patients enrolled in orlistat WMPs achieve clinically relevant weight loss and the majority of patients are satisfied with this weight loss. A programme such as the orlistat WMP is a useful tool for healthcare professionals to use in combination with orlistat treatment to help their patients achieve significant weight loss.
Low glycaemic index meals reduce dietary energy intake over six days in normal subjects. Norouzy A, Leeds AR, Emery PW, Frost G King's College London, London, UK Aims: To determine the effect of low glycaemic index (GI) meals on short-term (one-day) appetite and on energy intake over six days. Methods: 11 healthy subjects (5 M, 6 F) with normal body weight were recruited for this crossover study. On day one, an identical isocaloric (310 kcal) low or high GI breakfast and lunch was provided. Subjects completed visual analogue scales (VAS) to rate their hunger, satiety, feeling of fullness and prospective consumption every half an hour for the next 510 minutes. An ad-libitum buffet meal was provided 1.5 hours after lunch. For the next five days, a low or high GI lunch (GI 45 or 85) was provided and total dietary energy intake was measured using a weighed food diary. Results: The average daily energy intakes were 2930 kcal and 3268 kcal on the low and high GI diet respectively (p<0.007). Despite higher hunger feelings and lower satiety feelings at the majority of times on the high GI meal, none of the differences in subjective ratings was significant, nor was there a significant difference in intake of the ad-libitum buffet on day one. Conclusion: A medically meaningful and significant reduction of dietary energy intake (340 kcal/day) on a low GI diet was demonstrated over six days.
Mental health in obese children correlates to daily activity levels Nowicka P, Börjeson Munk U, Flodmark CE Childhood Obesity Unit, University Hospital, Malmö, Sweden Aims: To study the effect of a physical activity promoting group on daily physical activity and mental health in obese adolescents participating in an obesity treatment programme. Methods: Thirteen obese adolescents aged mean=12,5 years, mean BMI (Body Mass Index)=33.0 participating in a family therapy treatment programme for obesity were offered to start in an activity group. All adolescents completed the programme consisting of five weekly sessions of various sports. Before and after the programme weight, height, physical activity during three weekdays and one weekend day (using pedometer and diaries) and mental health measurements (using "I think I am") were performed. Results: Physical activity as counts per day, mental health and BMI did not change significantly before and after participating in the activity group. However, the activity was significantly higher in weekdays than during weekend days before but not after the sessions. Furthermore, a significant correlation was found between mental health and physical activity after but not before participating in the activity group. Conclusions: Improving mental health in obese adolescents might be an important part in treating obesity by facilitating physical activity. Aims: The effects of sibutramine on body weight and cardiovascular risk factors were assessed in a 6m study of obese patients (BMI 34,5±3,3kg/m 2 , age 42±10 years). Methods: 50 female patients were treated by sibutramine (10mg/d) plus the hypo caloric diet and physical activity advice for 6 months. 20% of the patients not losing 2 kg in the first month had their dosage increased to 15mg/d. Body composition assessment has been done by DXA. Results: 47 patients completed the study. Patients lost 12,2% of their initial weight and 13,5% of their waist circumference. Total and abdominal fat were significantly reduced (p<0,05) without changes in total lean mass. 56% of patients lost ≥ 10% of their initial weight and all patients (100%) lost ≥ 5% of their initial weight. Patients had a significant improvement (p<0,001) on all cardiovascular risk factors. Pretreatment body weight, lean mass, RMR and weight loss during the first 4-weeks were positively correlated (p<0,05) with total weight loss. 6% of the patients were withdrawn from the study because of adverse events. Dry mouth (9%), constipation (6%) and palpitations (5%) were the more frequent adverse events. Conclusions: Sibutramine promotes significant weight, fat and abdominal fat loss with improvement of cardiovascular risk factors and with a good tolerability in female obese patients. Novo Nordisk A/S Aims: This was a randomised, double-blind, parallel group, placebo-controlled trial investigating the effect of the novel long-acting GLP-1 derivative NN2211 on glycemic control, weight and body composition in obese subjects with type 2 diabetes. Methods: 33 patients (39 to 82 years), mean (± SD) HbA 1c 7.5 ± 1.2 % and BMI 36.6 ± 4.1 kg/m 2 were randomised to treatment with a single daily s.c. dose of 0.6 mg NN2211 (n=21) or placebo (PL) (n=12) for 8 weeks. In addition to glycemic parameters, body composition was assessed with DEXA. Results: After 8 weeks, NN2211 reduced fasting serum glucose (NN2211: -1.90 mmol/l; PL: 0.27 mmol/l, p=0.002), and HbA 1c (NN2211: -0.33 %; PL: 0.47 %, P=0.028) as compared with PL. No change in weight was detected (NN2211: -0.7 kg; PL: -0.9 kg, p=0.76). DEXA: total fat mass decreased (NN2211: -0.98%; PL: -0.12%, p=0.09), and lean body mass increased (NN2211: 1.02%; PL: 0.23%, p=0.12), although insignificantly, in the NN2211 group compared to PL. Conclusion: 8 weeks of low-dose NN2211 treatment significantly improved glycemic control without increasing weight in subjects with type 2 diabetes.
NN2211, a long-acting GLP-
Participation of health professionals and community in management of overweight: Finbalt Health Monitor study Petkeviciene J, Klumbiene J, Pudule I, Vähäsarja K, Helasoja V, Kasmel A Kaunas University of Medicine, Kaunas, Lithuania Aim: Effective management strategies of overweight require the common efforts of health care services and community. The aim of our study was to assess the participation of health professionals and family members in advising overweight people in Finland and Baltic countries. Methods: In 2000 postal surveys on health behaviours were conducted among representative national samples of adult population aged 20-64 years in Finland, Estonia, Latvia and Lithuania. The questions about height, weight and advises to change lifestyle were included into the questionnaire. Results: The prevalence of overweight (BMI>25) among men varied from 46% in Latvia to 56% in Finland, among women -from 39% in Finland to 49% in Latvia. Less than one fifth of overweight persons (14-18%) were advised by doctors to change dietary habits. Nurses were more active in giving dietary advises in Finland (13%) than in Baltic countries (2-4%). Almost one fourth of overweight persons received advises from family members (23-31%). Men were more often advised by family members than women. Conclusions: The involvement of health professionals in management of overweight should be strengthened in all the countries.
BIOIMPEDANCE ANALYSIS: IMPROVED PHENOTYPING WITH WHOLE-BODY ANALYSIS.
Pietrobelli A*^, Rubiano F^, Jones Jr. A^, Heymsfield SB^. *Pediatric Unit, Verona Univ Medical School, Italy, ^Obes Res Center, Columbia University, New York, USA. Aims: Bioimpedance analysis (BIA) is a potential field and clinical method for evaluating %fat and skeletal muscle mass (SM). A new system has 8 (2 on each hand and foot) rather than 4 (2 on each foot) contact electrodes allowing for rapid "whole-body" and regional body composition evaluation. Methods: This study evaluated the BC-418 8-electrode and TBF-310 4-electrode BIA systems (Tanita Corp., Tokyo). Subjects were 13 males and females, ages 10-64 yrs. BIA was evaluated on each subject and compared to reference estimates of %fat and appendicular lean soft tissue (ALST [kg]; a measure of extremity SM), by dual-energy x-ray absorptiometry (DXA; Lunar DPX, Madison, WI). Aims: To compare percentage body fat (%fat) estimates from air displacement plethysmography (ADP) and dual-energy xray absorptiometry (DXA) in overweight and obese children. Methods: 69 children, age (mean ±SD) 14.0 ±1.65y, body mass index 31.3 ±5.6kg.m -2 and %fat (DXA) 42.5 ±8.4% participated in the study. ADP %fat was estimated from body density (D b ) using equations devised by Siri (1961) (ADP Siri ) and Lohman (1986) (ADP Loh ). Results: ADP estimates of %fat were highly correlated with those of DXA in both male and female subjects (r≥8.8% p<0.001; SEE=2.66-3.53%). ADP Siri produced a nonsignificant mean underestimation of body fat content in males (-1.04%), and females (-0.64%). ADP Loh produced a significant mean underestimation in both males (-2.76%; p<0.001) and females (-2.74%; p<0.01). Total error ranged from 3.58 to 5.14. The 95% limits of agreement ranged from ±7.09% to ±8.58%. Conclusions: ADP and DXA %fat estimates are not interchangeable in overweight and obese children. 
Aims:
To investigate the long-term effects of a low-fat, highcarbohydrate diet with low (LGI) or high glycemic index (HGI) on ad libitum energy intake (EI), body weight (BW) and composition, as well as risk factors for type 2 diabetes and CHD. Methods: A 10-week intervention trial with two matched groups. The LGI and HGI test foods, given as part of the diet, were equal in energy content and density, dietary fibre and macronutrients. In vitro GI differed by 21 units. Subjects were 45 healthy women, 20-40 y, with a mean BMI of 27.7 kg/m 2 . Results: EI, BW (1.3 and 1.9 kg) and fat mass (0.4 and 1.0 kg) decreased similarly in LGI and HGI. There were no differences in serum insulin, HOMA-R or HOMA-ß, TAG, NEFA or HDL-cholesterol. However, a 10% decrease in LDLcholesterol (p<0.05) and a tendency to a larger decrease in total cholesterol (p=0.06) were observed in LGI vs HGI. Conclusions: This study does not support that low-fat, LGI diets are more beneficial than low-fat, HGI diets in appetite and body weight regulation. However, it supports a beneficial effect of LGI diets on risk factors for coronary heart disease. Aims: To assess the prevalence of Helicobacter infection in morbid obese patients and its incidence six months after the surgery. Methods: 73 patients with mean BMI=52,3 ±9,5 kg/m2, who underwent a Roux-en-Y gastric bypass operation were enrolled in this study. In all cases, an upper gastrointestinal endoscopy was performed and biopsy specimens were collected from gastric antrum and body for detection of H.pylori by urease production. After treatment with amoxicillin, clarithromycin and omeprazole, the urea breath test was used to confirm H.pylori eradication. Six months after the gastric bypass surgery, the breath test was repeated. Results: Prevalence of Helicobacter pylori infection was 65,8% in 73 obese patients. Endoscopic findings in 63 patients showed: antrum gastritis in 50,8%(32); normal in 27%(17) and another lesions in 22,2%(14). Out of 73 patients, 27 were evaluated for H.pylori before and 6 months after the surgery and we found 18,5%(5) of reinfection. Conclusion: The prevalence of H.Pylori in our patients was higher than general population. To validate that the treatment of helicobacter pylori before bypass gastric surgery is indeed effective, more data are necessary. Aims: Obesity has increased in the world rapidly. We present the need for alternative, integral & more effective methods. Method: Group of 220 patients between 25 to 60 years old of both sexes which initially presented obesity BMI of 30 to 55 and finally reached BMI under 25.All were included in a therapeutic, ambulatory, integrated and intensive program. Task is to reach the ideal weight +-5 kg(adequate weight). Immediate weight loss based on a nutritional scheme VLCD-SMR (Structured Meal Replacement) between 600-800 cal., supplemented with vitamins, minerals & a caloric hydration, alternating with a period of LCD, therapeutic groups (cognitive behavioral therapy)applied to approach the Dependant Addictive Link concept, Adapted Physical Activity and telephone follow up used to strengthen a Maintenance Protection Network Results: After 4 years in the program, there is no data on 35 patients. 32 re-gained 20% of the weight lost, 19 re-gained the weight and maintained contact with the clinic. Of the 134 remaining, kept continuity in programs, adapting the different resources to their needs resulting in a long term maintenance. Conclusion: A WLPII (Weight Loss Plan of Initial High Impact)supported with an integral therapeutic system, results in positive long term maintenance. Aim: The objective of this work is to study the possible relationships between the actual and perceived body weights of university students of the public University of Basque Country (UPV/EHU). Methods: A sample of 527 university student volunteers, 369 women (70%) and 158 men (30%) were selected at random. They were aged 18-29 years (mean±sd. 20.8±2.4 y). The BMI (weight(kg)/height(m 2 )) was estimated both from actual measurements (BMIO) and from subjective estimates (BMIS). Statistical treatment: SPSS 10.0 for Windows. Results: The BMIO and BMIS differ significantly (p=0.000) for both sexes. In all cases the BMIO values are higher than the BMIS, with a positive correlation (p=0.000, r=0.928) between them.
OBJECTIVE AND SUBJECTIVE BODY MASS INDEX IN A GROUP OF UNIVERSITY STUDENTS OF SPAIN
Men ( 
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Effectiveness of orlistat associated with mixed simvastatin in patients with dislipidemia. Robles Torres F. J., Reyes Cisneros F. A., De la Peña P. Cardiology, Carmen Hospital, Guadalajara, Jalisco Mexico
The statins as treatment at long term in dislipidemias is well known; however, the side effects are more frequent in higher doses. OBJECTIVE: Demonstrate the effectiveness of orlistat in: dislipidemia and obesity. Using concomitantly low doses of simvastatin. MATERIAL AND METHODS: Of a group of 249 obese treated with orlistat only who had dislipidemia were selected and submitted to therapy with concomitant simvastat comparing their lipids profile before, during 30 days of treatment with simvastatin and three months with orlistat concomitantly. Lipid profile was determined, with Cholestech LDX kit, RESULTS: 54 patients were studied, 21 males and 33 females. Aims : To develop a multidimensional medical and surgical patient-oriented approach for severe obesity. Methods : We evaluated from January 1999 to January 2003 467 patients (157 male, 310 female), mean age 48.1 ± 4.2 yrs, mean BMI 44.3 ± 4.9. During the first year pts obtained 5 days of hospitalisation, clinic follow up every 45 days, and after 6 months a 4 weeks in-house comprehensive treatment and education program. At the end of the first year of our multidimensional treatment we evaluated pts for a first bariatric step the BioEnterics Intragastric Ballon. Results : The multidimensional treatment after 36 months showed in our 103 pts enrolled during 1999: a) drop-out of 39 %; b) satisfactory medical treatment of 37% (with weight reduction > 15%);c) gastric banding (LAGB) of 14% (responsive to 6 months BIB test); d) gastric bypass procedure of 5% (with no BIB weight modification); e) a supportive psychological help and a healthy lifestyle patientoriented of 5% (not compliant to medical treatment and not candidate to surgical procedure). Conclusions : Our results after 3 years of multidimensional patient-oriented treatment could help family physicians to increase patients ' expectations of obesity outcomes.
ORLISTAT PLUS METFORMIN IS NOT RESULTED IN ADDITIONAL EFFECT ON WEIGHT LOSS AND INSULIN RESISTANCE
Sari R, Balci MK, Coban E, Yazicioglu G Akdeniz University, Antalya, Turkey
Aims: We aimed to compare the effect of orlistat or orlistat plus metformin combination therapy on weight loss and insulin resistance in obese women. Methods: Fifty-seven obese women (body mass index kg/m² and normal glucose tolerance) were included. All subjects took the same content and caloric diet therapy during the study. After a month of diet period, each individual was randomly assigned to receive 360 mg orlistat per day (group 1; n=30) or 360 mg orlistat plus 1700 mg metformin per day (group 2; n=27) during the next three months. Body weight, insulin resistance by the homeostasis model assessment model (Homa-r) was measured baseline, end of first month, and end of the study. Results: Body weight was decreased in groups 1 (p<0.001) and 2 (p<0.001), but there was no statistically significant difference between groups. Homa-r value was decreased in groups 1 (p<0.001) and 2 (p<0.001), but wasn't different between groups during study period. Conclusions: Combination of orlistat with metformin did not result an additional effect on weight loss and insulin resistance when compared to orlistat alone.
Prevalence of the Metabolic Syndrome in a Cohort of Swedish Obese Patients
Rössner S. Sjöström L, Boldrin M, Torgerson JS. Huddinge University Hospital, Stockholm, Sweden
Aims: The prevalence of metabolic syndrome (ms) was determined in a cohort of obese (BMI ≥ 30 kg/m 2 ) Swedish patients (pts) with normal (NGT, 79%) or impaired glucose tolerance (IGT, 21%) at baseline. Methods: Retrospective analysis of pts included in the 4 yr, double-blind, prospective XENDOS study (n=3277; ITT population). Pts who satisfied 3 of the ATP III criteria were defined as having ms. Results: Ms was identified in 1320/3277 (40%) pts (69% had NGT and 31% had IGT). In pts with ms the mean waist circumference at baseline was 117.3 cm vs 115.2 cm in the whole population (pts with/without ms). Mean lipid parameters were: triglycerides (2.5 vs 1.9 mmol/L); HDL-Cholesterol (1.0 vs 1.2 mmol/L), systolic and diastolic BP were 136.2 vs 130.6 mmHg and 85.8 vs 82.2 mmHg, respectively. Glycaemic control parameters at baseline were: fasting whole blood glucose (4.8 vs 4.6 mmol/L); insulin (98.3 vs 84.9 pmol/L). Conclusions: Baseline characteristics of this subgroup were consistent with the concept of 'clustering' of cardiovascular (cv) Results: In the 225 participants who completed the treatment and follow-up, there was a significant correlation between compliance to PTC and weight loss (WL). The level of compliance was also significantly correlated with the proportion of subjects who achieved 5% and 10% WL. Subjects who were highly compliant were 2.4 and 3.8 times more likely than subjects with low compliance to achieve 5% and 10% WL across all randomized treatment groups.
% subjects achieving Compliance % WL ≥5%WL ≥10%WL Aims: Laparoscopic gastric banding (LGB) is an effective treatment for morbid obesity and thus applied more frequently. There is, however, surprisingly little information about the nutrient intake of patients following this procedure. Methods: Dietary energy and vitamin intake of 9 women and 1 men (age 24-54, pre-OP weight 107-149 kg) was assessed by 5-day food records three months following LGB. Results: Three months after LGB total caloric intake was 1088±101 kcal/day (mean±SEM). Patients' vitamin intake was 47% lower than recommended by DACH (German, Austrian and Swiss Nutrition Societies) for retinol equivalentes, -79% for vitamin D, -63% for vitamin E, -46% for vitamin B1, -25% for vitamin B2, -29% for vitamin B6, -32% for vitamin B12, -67% for folic acid and -54% for vitamin C. Conclusions: Vitamin intake in patients following LGB was considerably lower than recommended. However, since the intake varied highly according to vitamin, it is strongly suggested to examine nutrient intake and nutritional status in order to warrant appropriate supply and workout evidence based recommendations concerning nutrient intake for LGBpatients.
Interactive weight management program for overweight patients: a new pilot project in Switzerland
Durrer-Schutz D, Schutz Y, Univ. of Lausanne, Switzerland.
Aim: To develop a 2-day (full-time) week-end workshop for overweight-obese patients in order to allow a better understanding of the physiological, nutritional, psychological and behavioral factors and their interactions leading to obesity. Methods: Three professional educators of medical and psychological background alternatively tought in small groups, (n=10). Practical workshops used pedagogic illustrative materials developed specifically for lay(wo)men. Exemples of workshops are: a) understanding body composition b) diagnosis of physical activity and fitness levels c) nutritional components: analysis of food labels after shoping in a supermarket d) calculation of own energy needs e) practical culinary counseling f) preventive aspects g) management of daily stress through practical exercises h) how to deal with eating disorders. Results: The evaluation of the program was based on the prospective evolution of body weight change at 12 months post-teaching (7.1kg weight loss) vs a control group which has not followed the program (2kg weight gain). Conclusion: A better understanding of the patient weight condition and obesity etiology is the cornerstone for an improved motivation and compliance to their treatment and to the prevention of weight gain. Results: In the 225 participants who completed the treatment and follow-up, there was a significant correlation between compliance to PTC and weight loss (WL). The level of compliance was also significantly correlated with the proportion of subjects who achieved 5% and 10% WL. Subjects who were highly compliant were 2.4 and 3.8 times more likely than subjects with low compliance to achieve 5% and 10% WL across all randomized treatment groups.
% , 1991, 1993) . By using this method, combining techniques of various psychotherapeutic schools, a reduction of internal stress and selfinjuring can be achieved.
Obese patients experience hunger attacks, which overwhelm them and result in feelings of inner tensions and a feeling of release after eating. These feelings are similar to the feelings of borderline personality disordered patients. At the Department of Psychiatry of the University Hospital Graz Linehan's skillstraining was modified and adapted for the treatment of obese women. A combination of weekly skillstraining and individual psychotherapy is used. The women learn to gain control over their eating habits and achieve a reduction of overeating and bingeing behavior. The DBT modules used are "eatingness", "distress tolerance", "mindfullness", "emotion regulation" and "interpersonal effectiveness". Personal needs, conflicts and frustrations are focused in the individual psychotherapy session taking place twice a week. In this poster the skillstraining concept for obese women will be demonstrated.
T4:P4-104
Using DBT to manage overeating -a casestudy Steinbrenner Birgit, Schönauer-Cejpek Martina Univ. Klinik für Psychiatrie Graz Dialectical Behavioral Psychotherapy (DBT) (Marsha M.Linehan, Archives of General Psychiatry, 1991 Psychiatry, , 1993 ) is a specific way of treating borderline personality disordered patients. In Graz, an adapted skills training program, derived from Linehan's concept, is used to treat obese women. By using DBT elements like "eatingness", "distress tolerance", "mindfullness", "emotion regulation" and "interpersonal effectiveness" the women learn to gain control over their eating habits and achieve a reduction of overeating and bingeing behavior. The women attend the skills training weekly in a group and individual psychotherapy twice a week. With this combined therapy, feelings of inner tension lessen, patients achieve a broader variety of ways to react when hungry or suffering from a hunger attack. As a result, they achieve a reduction of weight, get better control over their eating habits, learn to structure their days in a different way then around eating and altogether feel better. Depressive feelings, anxiety and inner tension decline and a higher quality of live is experienced. In this poster we want to demonstrate with a case study which major changes in the eating behavior can be achieved by the skills training and which effects these changes have on the over all treatment. Patients were assessed weekly using the Beck Depression Inventory (BDI), the State -Trait Anxiety Inventory (STAI), and a specifically developed daily protocol concerning hunger attacks, feelings of inner tension and feelings and thoughts towards eating and fasting. At begin and end of the therapy they were also assessed by the Fragebogen zum Essverhalten (FEVPudel und Westenhöfer). Conclusions: ORL has a significant impact on the cumulative incidence of T2D over 4 years in the overall XENDOS population as well as in cohorts of pts with IGTor metabolic syndrome.
XENDOS
The effect of sucrose on levels of C-reactive protein in overweight humans Sørensen LB, Raben A, Stender S, Astrup A Department of Human Nutrition, Copenhagen, Denmark, Aim: To investigate the effect of foods and drinks containing either sucrose (SUC) or artificial sweeteners (SW) on levels of C-reactive protein (CRP) in overweight humans. Methods: For 10 wk, overweight men and women consumed daily supplements of either sucrose (n=21) or artificial sweeteners (n=20), predominantly from soft drinks. Results: During the 10 wk, the sucrose intake increased in the SUC group by ∼ 250%, and decreased by ∼ 40% in the SW group. Body weight (BW) increased by 2.6 kg in the SUC group as compared to the SW group (P<0.001). Blood pressure increased in the SUC group and decreased in the SW group. CRP levels decreased by ∼ 15% in the SUC group and by ∼ 20% in the SW group (P=0.32). After excluding 4 subjects with CRP levels > 10 mg/L indicating infection, an increase in CRP levels by ∼ 100% in the SUC group and a decrease by ∼ 25% in the SW group was shown (P=0.10). Adjustment for BW changes did not influence on this result. Conclusion: A high intake of sugar-sweetened soft drinks increases BW, blood pressure, and may increase levels of CRP. The findings suggest that in the prevention of weight gain, type 2 diabetes and cardiovascular disease it is important to limit the intake of sugar-sweetened soft drinks. Introduction: Ghrelin is a gastric peptide with strong orexigenic and adipogenic effects. In obese subjects plasma ghrelin levels are decreased, increasing after weight loss; this increase is not observed after gastric bypass (BY). Prospective and comparable data after gastric banding (BA) have not been reported. Methods: Plasma ghrelin was measured in frequent intervals during 2 yrs. in morbidly obese subjects after BY (n=5), after BA (n=8), and in non-operated controls (n=7). Results: Body weight (BW) decreased by 29.5 ± 5.5kg (mean ± SEM, p<0.001), while plasma ghrelin failed to increase (+167 ± 119 pg/ml, n.s.) after BY, whereas BW decreased less (by 22.8 ±5.9 kg; p<0.001), and plasma ghrelin increased by 377 ± 201 pg/ml (p=0.025) after BA. Neither weight nor plasma ghrelin changed in non-operated controls (n=7). Plasma leptin decreased similarly in both operated groups (p<0.05). Conclusions: Plasma ghrelin failed to increase during weight loss after BY but increased after BA, suggesting that the smaller long-term weight loss after BA compared to BY is at least in part due to an absent increase in plasma ghrelin.
T4:P4-105
T4:P4-106 Effect of arachidonic acid supplement on blood glucose, insulin and leptin levels in type 2 diabetic patients St-Pierre S, Prins JB, Imbeault P University of Queensland, Brisbane, Australia.
Aims: Arachidonic acid (ϖ-6 Fatty Acid) may be beneficial in glucose homeostasis. The aim of this study was to evaluate the impact of an arachidonic acid (AA) oil supplement on blood glucose, insulin and leptin levels. Methods: Ten type 2 diabetic patients participated in a randomized cross-over trial which consisted of 2 periods of 3 weeks separated by a 2-week wash-out. Capsules of AA (0.8g) oil or placebo were taken daily during the treatments. Plasma glucose and insulin as well as leptin levels were measured before and after each period of treatment.
Results: No significant impact of treatments was observed on anthropometric measurements, fasting blood glucose, insulin and leptin levels. Conclusions: Even if previous results showed that AAphospholipids were positively associated with markers of insulin sensitivity, our results do not suggest a role for AA supplement in blood glucose control. This is the first intervention study reporting the impact of an AA supplement on blood glucose.
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Does long-term treatment with orlistat influence dietary fat in take in obese subjects? Svendsen M, Helgeland M, Tonstad S. Ullevål University Hospital, Oslo, Norway. Aim: We compared dietary intake in abdominally obese subjects with the metabolic syndrome treated with orlistat or placebo 1 year and 3 years after weight reduction using a very low calorie diet for 8 weeks.
Methods: Twenty-three women and 21 men aged 18-63 years with BMI 37.5±4.3 and waist circumference 116±11 cm were included in a multi-center, randomized, placebo controlled trial with orlistat. All participants received behavioral therapy to reduce dietary fat at individual and group sessions. The diet was assessed before weight reduction and after 1 and 3 years. The dietary assessment was done as an interview using a food frequency questionnaire. Results: Baseline energy (E)% intake from fat was similar in the orlistat and placebo groups (38% versus 36%; p=0.2). The E% from fat in the orlistat group was 29% ± 6 versus 25% ± 6 in the placebo group (p= 0.03) after 1 year. After 3 years the E% from fat was 30% ± 7 in the orlistat group and 29% ± 6 in the control group (p=0.8).
Conclusion: The reported E% from fat was lower in the placebo than in the orlistat group after 1 year, but similar in both groups after 3 years. In a program using behavioral therapy use of orlistat does not appear to have Methods: Nutrient data were collected on foods that had a "Low fat" or "Reduced fat" c laim and had a full fat (FF) equivalent available. Recipes for hi gh fat (HF) vegetablebased dishes were included if m ore than 30% energy was from fat but less than 10% saturated fat. The dietary intake data of f oods ( fluids r emoved) from t he 1995 National Nutrition Survey were used for the reference relationships between energy density (ED) and percent energy as fat and carbohydrate and percent water by weight.
Results: There were no significant relationships in the RF foods between ED and p ercent energy as fat o r carbohydrates. There w as no relationship in the HF vegetable-based dishes between ED and percent energy as fat. Conclusions: A high intake of products with RF claims could lead to an increase in ED of the di et and thu s promote weight gain. Alternatively a high intake of vegetable-based foods, even if the re is substantial added fat, could reduce ED and protect against weight gain. Aim: To evaluate the sub-chronic effect of mixtures of putative thermogenic food ingredients on 24-h energy expenditure (EE), energy intake and energy balance (EB). Methods: 19 obese (BMI: 25-35 kg/m 2 ) men participated in a 3-way crossover, randomised, placebo controlled, doubleblind study with each treatment period of 7 d separated by a >6 d wash-out. The supplements (one plain, one controlled release) contained green tea, tyrosine, caffeine, Ca 2+ and capsaicin or placebo and were taken t.i.d. 24-h EE was measured in respiration chambers on the 7 and last day of each treatment period. Energy intake (EI) was assessed the following day by an ad lib. breakfast. Results: The controlled release formulation had no effect on EI, 24-h EE, or 24-h EB. The simple formulation decreased ad lib EI by -315 ± 2438 kJ/d (2.9%), increased 24-h EE, adjusted for various confounders, by 181 ± 496 kJ/d (1.7%), and produced a deficit on EB of -201 ± 501 (adj. 189 ± 359 kJ/d) as compared to placebo, all NS. Conclusion: A 2% deficit on 24-h EB require further investigation before used in obesity treatment.
T4:P4-112
Usefulness of OGTT in obesity. Tufano A, Morricone L, Marzo P, Malavazos A, Ambrosi B. Endocrinology Unit, Istituto Policlinico SanDonato, University of Milan, Italy.
Aims : OGTT isnomore judged as necessary for the diagnosis of diabetes or impaired glucose tolerance (IGT), fasting plasma glucose (FPG) being considered sufficient. Nevertheless, impaired fasting glucose (IFG) or IGT are not coincident in the same individual patient (pt). Since obesity is a high-risk metabolic condition, in th is study we evaluated the prevalence of DM or IGT on the basis of FPG or OGTT in a wide population of obese pt s (OB) and we compared the results of the two procedures.
: 152 OB (132 F, 20 M; age 40.4±1.0 yr; BMI 37.2±0.5) underwent OGTT ( serum glucose and insulinat 0, 60', 120'). Insulin sensitivity was calculated by HOMA. Results: on the basis of FPG, 140 OB (92.1%) were normal, 6 (4.8%) were IFG and 6 had DM: all 12 IFG+DM pts were insulin-resistant (HOMA>2.7). By OGTT 92 OB (60.5%) were classified as normal, 42(27.6%) as IGT and 18 (11.8%) as DM: 30 /42 IGT pts and 17/ 18 DM were insulin-resistant. Conclusions: 1) OGTT is recommended in the evaluationof OB, evenin the presence ofnormal FPG; 2) OGTT allows to identify a high percentage (about 40%) of pts with IGT or DM, otherwise missed; in these cases a condition of in sulin resistance is also frequently found. ) and normal or impaired glucose tolerance (IGT) randomised to life style changes plus ORL 120 mg or PL tid for 4 yrs. Results: 52% of ORL-treated patients remained in the study at yr 4 compared with 34% for PL. The overall incidence of adverse events (AEs) was similar in the 2 groups, with the exception of a higher incidence of GI events with ORL vs PL. Patients withdrawals due to GI AEs was low (ORL 4%,PL <1%). The excess incidence of GI AEs with ORL decreased progressively over the 4-yr treatment period (yr 1: 76.6%; yr 2: 46.6%; yr 3:19.6%; yr 4: 7.9%). The majority of GI events were mild to moderate in intensity. Similar proportions of PL-and ORL-treated patients had at least 1 serious AE (13% vs 15%,respectively) but no deaths were attributed to study medication. Conclusions: XENDOS is the first study to demonstrate that over 4 yrs ORL has a similar safety profile to PL and is well tolerated in obese patients with normal glucose tolerance or IGT.vv T4:P4-113 Effect of doxazosin on insulin resistance in hypertensive patients with obesity Ueshiba H, Miyachi Y Toho University School of Medicine, Tokyo, Japan Aims: The purpose of this study is to know the effect of the alpha-blocker doxazosin on insulin resistance in hypertensive patients with obesity. Methods: Nineteen hypertensive patients, 10 men and 9 women, aged 55±11.0 years with obesity (BMI 26.7±1.9 ) were enrolled in the study. Patients received doxazosin 4mg/day. Fasting plasma glucose, fasting immunoreactive insulin(IRI), fasting plasma lipids, serum levels of TNF-alpha and leptin were measured at baseline and at 1, 2, 3, 6 and12 months of treatment. Insulin resistance was assessed using the homeostasis model assessment(HOMA-R). Results: Systolic and diastolic blood pressure were significantly decreased at one month of treatment. HOMA-R, IRI and total cholesterol were significantly reduced following treatment. Circulating TNF-alpha and leptin levels decreased significantly within 3 months of treatment. Leptin was independently associated with insulin resistance when adjusted for BMI. Conclusions: We conclude that doxazosin improves insulin resistance and dyslipidemia in obese hypertensive patients and has a beneficial effect on adipose endocrine activity.
T4:P4-114
Effect of Topiramate (TPM) on Body Composition (BC) Van 42 -4.72 -4.31 -3.84 The differences between the two methods showed no systematic variation over the range of actual change in FM or FFM or over the range of initial BMI. Conclusions: Using IMP to assess changes in body composition during weight loss in obese subjects appears valid for groups but is questionable at the individual level. EU grant QLK1-CT-2000-00618 visceral/subcutaneous ratio (V/S). Serious adverse events considered at least possibly related to drug by the investigator, occurred infrequently (<1% of subjects). These included but were not limited to suicidal thoughts or actions, depression, difficulty with concentration and attention, kidney stones, vertigo, psychosis, and increased hepatic enzymes. Conclusions: TPM significantly reduces weight and VAF.
